volume 26 issue 19 pages 7046-7055

Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2

Publication typeJournal Article
Publication date2006-10-01
scimago Q2
wos Q3
SJR0.988
CiteScore5.9
Impact factor2.7
ISSN02707306, 10985549
PubMed ID:  16980609
Molecular Biology
Cell Biology
Abstract
ABSTRACT Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF family that induces cancer cell death by apoptosis with some selectivity. TRAIL-induced apoptosis is mediated by the transmembrane receptors death receptor 4 (DR4) (also known as TRAIL-R1) and DR5 (TRAIL-R2). TRAIL can also bind decoy receptor 1 (DcR1) (TRAIL-R3) and DcR2 (TRAIL-R4) that fail to induce apoptosis since they lack and have a truncated cytoplasmic death domain, respectively. In addition, DcR1 and DcR2 inhibit DR4- and DR5-mediated, TRAIL-induced apoptosis and we demonstrate here that this occurs through distinct mechanisms. While DcR1 prevents the assembly of the death-inducing signaling complex (DISC) by titrating TRAIL within lipid rafts, DcR2 is corecruited with DR5 within the DISC, where it inhibits initiator caspase activation. In addition, DcR2 prevents DR4 recruitment within the DR5 DISC. The specificity of DcR1- and DcR2-mediated TRAIL inhibition reveals an additional level of complexity for the regulation of TRAIL signaling.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
Cancers
12 publications, 4.86%
International Journal of Molecular Sciences
7 publications, 2.83%
Apoptosis : an international journal on programmed cell death
7 publications, 2.83%
Cell Death and Differentiation
7 publications, 2.83%
PLoS ONE
6 publications, 2.43%
Journal of Biological Chemistry
6 publications, 2.43%
Frontiers in Immunology
5 publications, 2.02%
Oncogene
5 publications, 2.02%
Cancer Letters
5 publications, 2.02%
Oncotarget
4 publications, 1.62%
Cell Death and Disease
4 publications, 1.62%
Marine Drugs
3 publications, 1.21%
Cells
3 publications, 1.21%
Scientific Reports
3 publications, 1.21%
Journal of Molecular Biology
3 publications, 1.21%
Biomedicine and Pharmacotherapy
3 publications, 1.21%
Journal of Cellular and Molecular Medicine
3 publications, 1.21%
Resistance to Targeted Anti-Cancer Therapeutics
3 publications, 1.21%
Frontiers in Cell and Developmental Biology
2 publications, 0.81%
Journal of Immunology
2 publications, 0.81%
Future Oncology
2 publications, 0.81%
Frontiers in Oncology
2 publications, 0.81%
Nature Reviews Cancer
2 publications, 0.81%
Journal of Molecular Medicine
2 publications, 0.81%
Cell Communication and Signaling
2 publications, 0.81%
Chemistry - A European Journal
2 publications, 0.81%
BioFactors
2 publications, 0.81%
British Journal of Pharmacology
2 publications, 0.81%
Nanoscale
2 publications, 0.81%
2
4
6
8
10
12

Publishers

10
20
30
40
50
60
Springer Nature
54 publications, 21.86%
Elsevier
46 publications, 18.62%
MDPI
29 publications, 11.74%
Wiley
27 publications, 10.93%
Taylor & Francis
14 publications, 5.67%
Frontiers Media S.A.
12 publications, 4.86%
American Society for Biochemistry and Molecular Biology
7 publications, 2.83%
Public Library of Science (PLoS)
6 publications, 2.43%
Impact Journals
4 publications, 1.62%
American Association for Cancer Research (AACR)
4 publications, 1.62%
Royal Society of Chemistry (RSC)
3 publications, 1.21%
Hindawi Limited
3 publications, 1.21%
The American Association of Immunologists
2 publications, 0.81%
SAGE
2 publications, 0.81%
Spandidos Publications
2 publications, 0.81%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 0.81%
Oxford University Press
2 publications, 0.81%
American Chemical Society (ACS)
2 publications, 0.81%
Pleiades Publishing
2 publications, 0.81%
Springer New York
2 publications, 0.81%
IMR Press
2 publications, 0.81%
American Society for Clinical Investigation
1 publication, 0.4%
Bioscientifica
1 publication, 0.4%
Association for Research in Vision and Ophthalmology (ARVO)
1 publication, 0.4%
Portland Press
1 publication, 0.4%
American Association for the Advancement of Science (AAAS)
1 publication, 0.4%
Neoplasia Press
1 publication, 0.4%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.4%
Asian Pacific Organization for Cancer Prevention
1 publication, 0.4%
10
20
30
40
50
60
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
247
Share
Cite this
GOST |
Cite this
GOST Copy
Merino D. et al. Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2 // Molecular and Cellular Biology. 2006. Vol. 26. No. 19. pp. 7046-7055.
GOST all authors (up to 50) Copy
Merino D., Lalaoui N., Morizot A., Schneider P., Solary E., Micheau O. Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2 // Molecular and Cellular Biology. 2006. Vol. 26. No. 19. pp. 7046-7055.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1128/MCB.00520-06
UR - https://doi.org/10.1128/MCB.00520-06
TI - Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2
T2 - Molecular and Cellular Biology
AU - Merino, Delphine
AU - Lalaoui, Najoua
AU - Morizot, Alexandre
AU - Schneider, Pascal
AU - Solary, E
AU - Micheau, Olivier
PY - 2006
DA - 2006/10/01
PB - American Society for Microbiology
SP - 7046-7055
IS - 19
VL - 26
PMID - 16980609
SN - 0270-7306
SN - 1098-5549
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2006_Merino,
author = {Delphine Merino and Najoua Lalaoui and Alexandre Morizot and Pascal Schneider and E Solary and Olivier Micheau},
title = {Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2},
journal = {Molecular and Cellular Biology},
year = {2006},
volume = {26},
publisher = {American Society for Microbiology},
month = {oct},
url = {https://doi.org/10.1128/MCB.00520-06},
number = {19},
pages = {7046--7055},
doi = {10.1128/MCB.00520-06}
}
MLA
Cite this
MLA Copy
Merino, Delphine, et al. “Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2.” Molecular and Cellular Biology, vol. 26, no. 19, Oct. 2006, pp. 7046-7055. https://doi.org/10.1128/MCB.00520-06.